Commercialization
Finding Balance: A Decentralized Trial Strategy to Help Sponsors Address the New FDA Draft Guidance
The world is full of tradeoffs—it’s the way progress is made while proportionately managing ...
10 Trends in 2023 that Will Reshape the Pharma Industry
2023 is poised to be a transformative year for the pharma industry, even more ...
Making Clinical Trials Better for Everyone in 2023
Getting clinical trials to the finish line is not easy. Between 15% to 40% ...
Two Key Questions About Clinical Trials in 2023
PM360 asked experts in clinical trials about the evolution of decentralized research and what ...
What Does It Take to Design a Patient-centric Clinical Trial Protocol?
Clinical trial protocol writing teams usually start with scientific objectives, and ideally with the ...
Evolution of ePROM: Advancements, Concerns, and the Way Forward
Patients’ directly reported outcomes in certain rare and chronic diseases are considered reliable for ...
The Evolution of Biosimilars from Their Beginning Until Now—And What’s Next
Chrys Kokino has been involved in the biosimilars market prior to the first biosimilar ...
Digital Thread Solutions Can Speed Scale-up and Shorten Time to Market for Pharma
In the pharmaceutical business, as with any other business, you can’t market what you ...
Seven Strategies for Succeeding as a Small Fish in a Big Pond
The biotech sector has seen its fair share of unsettling dynamics over the past ...
Set Your Trial Up for Success—Select Your CRO and Decentralized Vendors in Parallel
Selecting the right Contract Research Organization (CRO) for your clinical trial is a common ...
New Developments in Gynecological Cancer Research
Substantial unmet needs exist in the diagnosis and treatment of gynecologic cancers. Often, these ...
Deploying AI for Greater Efficiency in Clinical Trial Recruitment
Clinical trial recruitment is a lengthy and complex process involving stringent protocols and the ...
Digital Therapeutics Companies Lean into Decentralized Clinical Trials
While digital therapeutics (DTx) companies are extremely optimistic about the promise of software-based interventions ...
